Literature DB >> 32488245

Effectiveness of a Khorasan Wheat-Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia.

Giuditta Pagliai1,2, Barbara Colombini1, Monica Dinu1,2, Anne Whittaker3, Alberto Masoni1, Giovanna Danza1, Amedeo Amedei1, Giovanna Ballerini4, Stefano Benedettelli3, Francesco Sofi1,2,5.   

Abstract

OBJECTIVE: To investigate the effects of a replacement diet with Khorasan wheat products in patients with fibromyalgia, in comparison with a similar replacement diet with control products made from organic semi-whole-grain modern wheat.
DESIGN: Randomized, double-blinded crossover trial.
SETTING: Outpatient clinic.
SUBJECTS: Twenty subjects (19 female and one male, mean age = 48.9 ± 12.3 years) with fibromyalgia.
METHODS: Participants were randomly assigned to consume either Khorasan or control wheat products (pasta, bread, crackers, biscuits) for eight weeks and then crossed. Validated self-administered questionnaires were collected from each subject at the beginning and end of each intervention period.
RESULTS: A general linear model for repeated measurement, adjusted for potential confounders, showed that the overall score reported from each questionnaire improved after both intervention and control periods, but the effect was more evident after the intervention with Khorasan. In particular, a statistically significant difference in Widespread Pain Index (WPI) + Severity Scale (SS) and Functional Outcome of Sleep Questionnaire (FOSQ) was observed, which decreased significantly by 21.5% and 11.7% respectively, only after the Khorasan period, while no statistically significant variations were reported after the control period. Similarly, FM Impact Questionnaire scores decreased significantly only after the Khorasan period, with a reduction that was significantly different between the intervention and control periods (-22.5% vs -0.3%, P = 0.037). The improvement was even greater in people with higher symptom severity.
CONCLUSIONS: A dietary intervention with Khorasan wheat products seems to benefit patients with fibromyalgia, especially those with greater symptom severity.
© The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ancient Grains; Cereals; Diet; Fibromyalgia; Khorasan

Mesh:

Year:  2020        PMID: 32488245     DOI: 10.1093/pm/pnaa134

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  4 in total

Review 1.  Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures.

Authors:  Annika Döhmen; Milan Kock; Alexander Obbarius; Christoph Paul Klapproth; Felix Fischer; Matthias Rose
Journal:  Qual Life Res       Date:  2022-10-01       Impact factor: 3.440

2.  Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia.

Authors:  Simone Baldi; Giuditta Pagliai; Monica Dinu; Leandro Di Gloria; Giulia Nannini; Lavinia Curini; Marco Pallecchi; Edda Russo; Elena Niccolai; Giovanna Danza; Stefano Benedettelli; Giovanna Ballerini; Barbara Colombini; Gianluca Bartolucci; Matteo Ramazzotti; Francesco Sofi; Amedeo Amedei
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

3.  Nutritional Interventions in the Management of Fibromyalgia Syndrome.

Authors:  Giuditta Pagliai; Ilaria Giangrandi; Monica Dinu; Francesco Sofi; Barbara Colombini
Journal:  Nutrients       Date:  2020-08-20       Impact factor: 5.717

4.  Effect of ancient wheat pasta on gut microbiota composition and bacteria-derived metabolites: A randomized controlled trial.

Authors:  Simone Baldi; Monica Dinu; Giuditta Pagliai; Barbara Colombini; Leandro Di Gloria; Lavinia Curini; Marco Pallecchi; Matteo Ramazzotti; Gianluca Bartolucci; Stefano Benedettelli; Amedeo Amedei; Francesco Sofi
Journal:  Front Nutr       Date:  2022-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.